Routine NHS access to spinal muscular atrophy treatments offers new hope for patients and families
Posted:
SMA is a rare, inherited condition that causes progressive muscle weakness, affecting movement, breathing and swallowing. People living with spinal muscular atrophy (SMA) in England are set to gain routine access to two potentially life-changing treatments, following our publication of final draft guidance today.
Microsoft announced a strategic partnership with Mayo Clinic to develop and deploy a frontier AI model specifically for healthcare, combining Mayo Clinic's clinical expertise with the tech giant's technologies.
Read more here.
Healthcare is evolving faster than ever — driven by digital transformation, AI, new care models, and increasing pressure on health systems to deliver better outcomes with fewer resources.
But innovation only works when the right people come together in the…